Gary Chrebet

1.9k total citations · 1 hit paper
20 papers, 1.6k citations indexed

About

Gary Chrebet is a scholar working on Molecular Biology, Organic Chemistry and Immunology. According to data from OpenAlex, Gary Chrebet has authored 20 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 4 papers in Organic Chemistry and 3 papers in Immunology. Recurrent topics in Gary Chrebet's work include Sphingolipid Metabolism and Signaling (11 papers), Lipid Membrane Structure and Behavior (6 papers) and Signaling Pathways in Disease (5 papers). Gary Chrebet is often cited by papers focused on Sphingolipid Metabolism and Signaling (11 papers), Lipid Membrane Structure and Behavior (6 papers) and Signaling Pathways in Disease (5 papers). Gary Chrebet collaborates with scholars based in United States. Gary Chrebet's co-authors include Mark W. Rolfe, Rodney Rothstein, John W. Wallis, Gary Brodsky, Stephen A. Parent, Keith A. Bostian, Nancy R. Morin, Jennifer Nielsen, Ming Jo Hsu and Suzanne Mandala and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Gary Chrebet

20 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A hyper-recombination mutation in S. cerevisiae identifies a novel eukaryotic topoisomerase

1989 484 citations John W. Wallis, Gary Chrebet et al. Cell profile →

Peers

Countries citing papers authored by Gary Chrebet

Since Specialization

Citations

This map shows the geographic impact of Gary Chrebet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Chrebet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Chrebet more than expected).

Fields of papers citing papers by Gary Chrebet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Chrebet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Chrebet. The network helps show where Gary Chrebet may publish in the future.

Co-authorship network of co-authors of Gary Chrebet

This figure shows the co-authorship network connecting the top 25 collaborators of Gary Chrebet. A scholar is included among the top collaborators of Gary Chrebet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Chrebet. Gary Chrebet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identification of Leu276 of the S1P1 Receptor and Phe263 of the S1P3 Receptor in Interaction with Receptor Specific Agonists by Molecular Modeling, Site-Directed Mutagenesis, and Affinity Studies 2006 ·Molecular Pharmacology ·Qiaolin Deng, Joseph Clemas, Gary Chrebet, Paul Fischer, Jeffrey J. Hale, Zhen Li, Sander G. Mills, James D. Bergstrom, Suzanne Mandala, Ralph Mosley, Stephen A. Parent	32
2	Highly selective and potent agonists of sphingosine-1-phosphate 1 (S1P1) receptor 2006 ·Bioorganic & Medicinal Chemistry Letters ·Petr Váchal, (unknown), Jeffrey J. Hale, Lin Yan, Sander G. Mills, Gary Chrebet, (unknown), Richard Hajdu, James A. Milligan, Mark Rosenbach, Suzanne Mandala	29
3	Discovery of 3-arylpropionic acids as potent agonists of sphingosine-1-phosphate receptor-1 (S1P1) with high selectivity against all other known S1P receptor subtypes 2006 ·Bioorganic & Medicinal Chemistry Letters ·Lin Yan, (unknown), George Doherty, (unknown), Jeffrey J. Hale, Sander G. Mills, Richard Hajdu, Carol Keohane, Mark Rosenbach, James A. Milligan, Gan-Ju Shei, Gary Chrebet, James D. Bergstrom, Deborah Card, Elizabeth J. Quackenbush, (unknown), Suzanne Mandala	15
4	2-Aryl(pyrrolidin-4-yl)acetic acids are potent agonists of sphingosine-1-phosphate (S1P) receptors 2006 ·Bioorganic & Medicinal Chemistry Letters ·Lin Yan, Richard J. Budhu, (unknown), Christopher L. Lynch, Jeffrey J. Hale, Sander G. Mills, Richard Hajdu, Carol Keohane, Mark Rosenbach, James A. Milligan, Gan-Ju Shei, Gary Chrebet, James D. Bergstrom, Deborah Card, Suzanne Mandala	18
5	SAR studies of 3-arylpropionic acids as potent and selective agonists of sphingosine-1-phosphate receptor-1 (S1P1) with enhanced pharmacokinetic properties 2006 ·Bioorganic & Medicinal Chemistry Letters ·Lin Yan, (unknown), Jeffrey J. Hale, Sander G. Mills, Richard Hajdu, Carol Keohane, Mark Rosenbach, James A. Milligan, Gan-Ju Shei, Gary Chrebet, James D. Bergstrom, Deborah Card, Suzanne Mandala	18
6	Cell-Based Assays to Detect Inhibitors of Fungal mRNA Capping Enzymes and Characterization of Sinefungin as a Cap Methyltransferase Inhibitor 2005 ·SLAS DISCOVERY ·Gary Chrebet, Douglas Wisniewski, (unknown), Qiaolin Deng, Myra B. Kurtz, Alice I. Marcy, Stephen A. Parent	26
7	Specific Substitutions in the Echinocandin Target Fks1p Account for Reduced Susceptibility of Rare Laboratory and Clinical Candida sp. Isolates 2005 ·Antimicrobial Agents and Chemotherapy ·(unknown), Rosemarie Kelly, Jennifer Nielsen Kahn, Juan Robles, Ming Jo Hsu, Elizabeth Register, (unknown), Valmik K. Vyas, Hongxia Fan, George K. Abruzzo, Amy Flattery, Christopher Gill, Gary Chrebet, Stephen A. Parent, Martha Kurtz, Hedy Teppler, Cameron Douglas, David S. Perlin	347
8	Potent S1P receptor agonists replicate the pharmacologic actions of the novel immune modulator FTY720 2004 ·Bioorganic & Medicinal Chemistry Letters ·Jeffrey J. Hale, William Neway, Sander G. Mills, Richard Hajdu, Carol Keohane, Mark Rosenbach, James A. Milligan, Gan-Ju Shei, Gary Chrebet, James D. Bergstrom, Deborah Card, Gloria C. Koo, Sam L. Koprak, Jesse J. Jackson, Hugh Rosen, Suzanne Mandala	64
9	Synthesis, stereochemical determination and biochemical characterization of the enantiomeric phosphate esters of the novel immunosuppressive agent FTY720 2004 ·Bioorganic & Medicinal Chemistry ·Jeffrey J. Hale, Lin Yan, William Neway, Richard Hajdu, James D. Bergstrom, James A. Milligan, Gan-Ju Shei, Gary Chrebet, Rosemary Thornton, Deborah Card, Mark Rosenbach, (unknown), Suzanne Mandala	39
10	Selecting against S1P3 enhances the acute cardiovascular tolerability of 3-(N-benzyl)aminopropylphosphonic acid S1P receptor agonists 2004 ·Bioorganic & Medicinal Chemistry Letters ·Jeffrey J. Hale, George Doherty, (unknown), Sander G. Mills, Richard Hajdu, Carol Keohane, Mark Rosenbach, James A. Milligan, Gan-Ju Shei, Gary Chrebet, James D. Bergstrom, Deborah Card, Michael J. Forrest, (unknown), Sarah J. West, Huijuan Xie, Naomi Nomura, Hugh Rosen, Suzanne Mandala	39
11	The discovery of 3-(N-alkyl)aminopropylphosphonic acids as potent S1P receptor agonists 2004 ·Bioorganic & Medicinal Chemistry Letters ·Jeffrey J. Hale, George Doherty, (unknown), (unknown), Sander G. Mills, Richard Hajdu, Carol Keohane, Mark Rosenbach, James A. Milligan, Gan-Ju Shei, Gary Chrebet, James D. Bergstrom, Deborah Card, Hugh Rosen, Suzanne Mandala	26
12	Design and synthesis of conformationally constrained 3-(N-alkylamino)propylphosphonic acids as potent agonists of sphingosine-1-phosphate (S1P) receptors 2004 ·Bioorganic & Medicinal Chemistry Letters ·Lin Yan, Jeffrey J. Hale, Christopher L. Lynch, Richard J. Budhu, (unknown), Sander G. Mills, Richard Hajdu, Carol Keohane, Mark Rosenbach, James A. Milligan, Gan-Ju Shei, Gary Chrebet, James D. Bergstrom, Deborah Card, Hugh Rosen, Suzanne Mandala	23
13	A Rational Utilization of High-Throughput Screening Affords Selective, Orally Bioavailable 1-Benzyl-3-carboxyazetidine Sphingosine-1-phosphate-1 Receptor Agonists 2004 ·Journal of Medicinal Chemistry ·Jeffrey J. Hale, Christopher L. Lynch, William Neway, Sander G. Mills, Richard Hajdu, Carol Keohane, Mark Rosenbach, James A. Milligan, Gan-Ju Shei, Stephen A. Parent, Gary Chrebet, James D. Bergstrom, Deborah Card, Marc Ferrer, Peter Hodder, Berta Strulovici, Hugh Rosen, Suzanne Mandala	65
14	Molecular characterization of the murine SIGNR1 gene encoding a C-type lectin homologous to human DC-SIGN and DC-SIGNR 2002 ·Gene ·Stephen A. Parent, Theresa Zhang, Gary Chrebet, Joseph Clemas, David J. Figueroa, Betty Ky, Richard Blevins, Christopher P. Austin, Hugh Rosen	19
15	Calcineurin-dependent growth of an FK506- and CsA-hypersensitive mutant of Saccharomyces cerevisiae 1993 ·Journal of General Microbiology ·Stephen A. Parent, Jennifer Nielsen, Nancy R. Morin, Gary Chrebet, (unknown), (unknown), Ming Jo Hsu, Keith A. Bostian, F Foor	52
16	Calcineurin mediates inhibition by FK506 and cyclosporin of recovery from α-factor arrest in yeast 1992 ·Nature ·(unknown), Stephen A. Parent, Nancy R. Morin, (unknown), (unknown), Gary Chrebet, Keith A. Bostian, Jennifer Nielsen	179
17	Yeast FKBP-13 is a membrane-associated FK506-binding protein encoded by the nonessential gene FKB2. 1992 ·Proceedings of the National Academy of Sciences ·Jennifer Nielsen, F Foor, John J. Siekierka, Ming Jo Hsu, (unknown), Nancy R. Morin, Ali Shafiee, (unknown), Leonardo Brizuela, Gary Chrebet	49
18	Antifungal properties of the immunosuppressant FK-506: identification of an FK-506-responsive yeast gene distinct from FKB1. 1991 ·Molecular and Cellular Biology ·Leonardo Brizuela, Gary Chrebet, Keith A. Bostian, Stephen A. Parent	38
19	Antifungal Properties of the Immunosuppressant FK-506: Identification of an FK-506-Responsive Yeast Gene Distinct from FKB1 1991 ·Molecular and Cellular Biology ·Leonardo Brizuela, Gary Chrebet, Keith A. Bostian, Stephen A. Parent	1
20	A hyper-recombination mutation in S. cerevisiae identifies a novel eukaryotic topoisomerase breakdown → 1989 ·Cell ·John W. Wallis, Gary Chrebet, Gary Brodsky, Mark W. Rolfe, Rodney Rothstein	484

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact